Results · Apr-Jun 2026
Mercury Laboratories Q1 FY27 results
Sales fell 12% to ₹16 crore from ₹18.1 crore in Apr-Jun 2025.
Operating profit fell 49% to ₹1.2 crore, an operating margin of 7.5% (down 5.5 points from a year ago).
Net profit fell 69% to ₹0.3 crore from ₹0.97 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −22%, net profit −76%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 16.0 | 18.1 | −12% |
| Operating profit (EBITDA) | 1.2 | 2.4 | −49% |
| Operating margin | 7.5% | 13.0% | −5.5 pts |
| Net profit | 0.3 | 1.0 | −69% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.